Pathology of myxomatous mitral valve disease in the dog.
Fox PR.
J Vet Cardiol. 2012 Mar;14(1):103-26. doi: 10.1016/j.jvc.2012.02.001. Epub 2012 Mar 3.
Structural valve degeneration in the transcatheter mitral valve implantation era.
Narayan P.
J Card Surg. 2021 Nov;36(11):4431-4433. doi: 10.1111/jocs.15911. Epub 2021 Aug 9.
Mitral Valve Pathology.
Fishbein GA, Fishbein MC.
Curr Cardiol Rep. 2019 May 23;21(7):61. doi: 10.1007/s11886-019-1145-5.
Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-beta mechanisms.
Oyama MA, Elliott C, Loughran KA, Kossar AP, Castillero E, Levy RJ, Ferrari G.
Cardiovasc Pathol. 2020 May-Jun;46:107196. doi: 10.1016/j.carpath.2019.107196. Epub 2020 Jan 7.
The Mitral Annular Disjunction of Mitral Valve Prolapse: Presentation and Outcome.
Essayagh B, Sabbag A, Antoine C, Benfari G, Batista R, Yang LT, Maalouf J, Thapa P, Asirvatham S, Michelena HI, Enriquez-Sarano M.
JACC Cardiovasc Imaging. 2021 Nov;14(11):2073-2087. doi: 10.1016/j.jcmg.2021.04.029. Epub 2021 Jun 16.
The mechanobiology of mitral valve function, degeneration, and repair.
Richards JM, Farrar EJ, Kornreich BG, Moїse NS, Butcher JT.
J Vet Cardiol. 2012 Mar;14(1):47-58. doi: 10.1016/j.jvc.2012.01.002. Epub 2012 Feb 25.
Signaling pathways in mitral valve degeneration.
Orton EC, Lacerda CM, MacLea HB.
J Vet Cardiol. 2012 Mar;14(1):7-17. doi: 10.1016/j.jvc.2011.12.001. Epub 2012 Feb 23.
Transcatheter mitral valve replacement.
Enta Y, Nakamura M.
J Cardiol. 2021 Jun;77(6):555-564. doi: 10.1016/j.jjcc.2020.10.020. Epub 2020 Nov 25.
Mitral valve prolapse.
Wigle ED, Rakowski H, Ranganathan N, Silver MC.
Annu Rev Med. 1976;27:165-80. doi: 10.1146/annurev.me.27.020176.001121.
Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.
Simard T, Lloyd J, Crestanello J, Thaden JJ, Alkhouli M, Guerrero M, Rihal CS, Eleid MF.
Catheter Cardiovasc Interv. 2022 Apr;99(5):1659-1665. doi: 10.1002/ccd.30059. Epub 2022 Jan 12.
